Catherine M. Szyman - Sep 3, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Sep 3, 2024
Transactions value $: -$386,879
Form type: 4
Date filed: 9/3/2024, 07:10 PM
Previous filing: Jul 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+10.9K	+14.37%	$0.00	86.8K	Sep 3, 2024	Direct	F1
transaction	EW	Common Stock	Tax liability	-$387K	-5.53K	-6.37%	$69.96	81.3K	Sep 3, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on September 3, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are 100% vested and exercisable on the grant date.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.